181 related articles for article (PubMed ID: 15737239)
41. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.
Albers HM; Dong A; van Meeteren LA; Egan DA; Sunkara M; van Tilburg EW; Schuurman K; van Tellingen O; Morris AJ; Smyth SS; Moolenaar WH; Ovaa H
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7257-62. PubMed ID: 20360563
[TBL] [Abstract][Full Text] [Related]
42. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
[TBL] [Abstract][Full Text] [Related]
43. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
44. Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe.
Kawaguchi M; Okabe T; Okudaira S; Nishimasu H; Ishitani R; Kojima H; Nureki O; Aoki J; Nagano T
ACS Chem Biol; 2013 Aug; 8(8):1713-21. PubMed ID: 23688339
[TBL] [Abstract][Full Text] [Related]
45. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
[TBL] [Abstract][Full Text] [Related]
46. Lysophospholipase D and its role in LPA production.
Xie Y; Meier KE
Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
[TBL] [Abstract][Full Text] [Related]
47. Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
Clair T; Lee HY; Liotta LA; Stracke ML
J Biol Chem; 1997 Jan; 272(2):996-1001. PubMed ID: 8995394
[TBL] [Abstract][Full Text] [Related]
48. Characterization of non-lipid autotaxin inhibitors.
Hoeglund AB; Howard AL; Wanjala IW; Pham TC; Parrill AL; Baker DL
Bioorg Med Chem; 2010 Jan; 18(2):769-76. PubMed ID: 20005724
[TBL] [Abstract][Full Text] [Related]
49. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.
Saunders LP; Ouellette A; Bandle R; Chang WC; Zhou H; Misra RN; De La Cruz EM; Braddock DT
Mol Cancer Ther; 2008 Oct; 7(10):3352-62. PubMed ID: 18852138
[TBL] [Abstract][Full Text] [Related]
50. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
Billon-Denis E; Tanfin Z; Robin P
J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
[TBL] [Abstract][Full Text] [Related]
51. alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitors.
Cui P; McCalmont WF; Tomsig JL; Lynch KR; Macdonald TL
Bioorg Med Chem; 2008 Mar; 16(5):2212-25. PubMed ID: 18082408
[TBL] [Abstract][Full Text] [Related]
52. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.
Kanda H; Newton R; Klein R; Morita Y; Gunn MD; Rosen SD
Nat Immunol; 2008 Apr; 9(4):415-23. PubMed ID: 18327261
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of inhibitory actions of flavonols and related substances on lysophospholipase d activity of serum autotaxin by a convenient assay using a chromogenic substrate.
Ueda K; Yoshihara M; Nakao M; Tanaka T; Sano S; Fukuzawa K; Tokumura A
J Agric Food Chem; 2010 May; 58(10):6053-63. PubMed ID: 20415488
[TBL] [Abstract][Full Text] [Related]
54. Discovery and optimization of boronic acid based inhibitors of autotaxin.
Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
[TBL] [Abstract][Full Text] [Related]
55. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
[TBL] [Abstract][Full Text] [Related]
56. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation.
Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM
Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039
[TBL] [Abstract][Full Text] [Related]
57. Measurement of autotaxin/lysophospholipase D activity.
Morris AJ; Smyth SS
Methods Enzymol; 2007; 434():89-104. PubMed ID: 17954243
[TBL] [Abstract][Full Text] [Related]
58. Autotaxin promotes the expression of matrix metalloproteinase-3 via activation of the MAPK cascade in human fibrosarcoma HT-1080 cells.
Haga A; Nagai H; Deyashiki Y
Cancer Invest; 2009 May; 27(4):384-90. PubMed ID: 19212832
[TBL] [Abstract][Full Text] [Related]
59. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood.
Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J
J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959
[TBL] [Abstract][Full Text] [Related]
60. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H; Stracke ML; Nakamura H; Sano K
Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
